Acquisition

11th September 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, "Exchange Plaza", 5th Floor, Dalal Street, Fort, Plot No. C/1, G Block Bandra-Kurla Complex Mumbai 400 001 Bandra (East), Mumbai 400 051 Scrip code: 504058 NSE SYMBOL: NIPPOBATRY Dear Sir/Madam, Sub: Intimation under Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR”), as amended read with the Securities and Exchange Board of India (“SEBI”) master circular dated November 11, 2024, bearing reference no. SEBI/HO/CFD/PoD2/CIR/P/0155 (“SEBI Circular”) Pursuant to the provisions of Regulation 30 of the SEBI LODR, we would like to inform that the Company has invested an aggregate amount of Rs. 25,01,968 (Rupees Twenty-Five Lakh One Thousand Nine Hundred Sixty-Eight only), by way of subscription to Equity Shares of Medcuore Medical Solutions Private Ltd (“MMSPL”). The said investment represents an additional 0.41% of the paid-up share capital in MMSPL on a fully diluted basis. The disclosure required under Schedule III of the SEBI LODR read with the SEBI Circular, is enclosed herewith as Annexure-A. Kindly take the above on your record. For Indo National Limited J. Srinivasan Company Secretary lndo National Limited I Corporate office address: Pottipati Plaza, 3rd Floor, 77, Nungambakkam High Road, Chennai – 600034. Registered office address: No. 609, Mount Road, Lakshmi Bhawan IVth FLOOR, Chennai- 600006. CIN No: L31909TN1972PLC006196 I feedback@nippo.in I 044-2827 2711, 044-2824 2700 I www.nippo.in ANNEXURE – A Disclosure of information as required under SEBI circular are as follows:- Particulars Details 1. n ame of the target entity, details in Name: Medcuore Medical Solutions Private Ltd brief such as size, turnover etc.; Turnover (FY 25-26): Rs. 1,45,60,000 2. w hether the acquisition would fall Pursuant to an additional primary investment of Rs. within related party transaction(s) 25,01,968, the Company has acquired a further 0.41% and whether the promoter/ equity stake in MMSPL. Following this acquisition, the promoter group/ group companies Company’s aggregate shareholding in MMSPL now stands have any interest in the entity being at 62.28%. The acquisition would not fall under related acquired? If yes, nature of interest party transaction. None of the promoter/ promoter group/ and details thereof and whether the group companies have any interest in the entity being same is done at “arm’s length” acquired. 3. I ndustry to which the entity being MMSPL is engaged in the business of manufacturing, acquired belongs distribution and providing services in relation to Air Monitoring System and Air Purifiers. 4. o bjects and impact of acquisition Object and impact: To facilitate business growth and to (including but not limited to, generate revenue and to earn profit due to expansion of disclosure of reasons for acquisition business of target entity, if its business is outside the main line of business of the listed entity); 5. b rief details of any governmental or Nil regulatory approvals required for the acquisition; 6. I ndicative time period for Upto FY 2027-28 completion of the acquisition 7. C onsideration- whether cash Cash consideration consideration or share swap or any other form and details of the same. lndo National Limited I Corporate office address: Pottipati Plaza, 3rd Floor, 77, Nungambakkam High Road, Chennai – 600034. Registered office address: No. 609, Mount Road, Lakshmi Bhawan IVth FLOOR, Chennai- 600006. CIN No: L31909TN1972PLC006196 I feedback@nippo.in I 044-2827 2711, 044-2824 2700 I www.nippo.in Particulars Details 8. C ost of acquisition and/or the price 178 shares were acquired based on valuation report issued at which the shares are acquired; by registered valuer dated August 21, 2026. The price per share is Rs. 14,056/- (Rupees Fourteen Thousand and Fifty Six). 9. P ercentage of shareholding / An additional 0.41% of the paid-up share capital in MMSPL control acquired and / or number of has been acquired, taking the Company’s total shareholding shares acquired to 62.28%. Number of shares acquired: 178 shares 10. B rief background about the entity a. Name: Medcuore Medical Solutions Private Ltd acquired in terms of products/line of business acquired, date of b. Product and Line of Business: business of manufacturing, incorporation, history of last 3 years distribution and providing services in relation to Air turnover, country in which the Monitoring System and Air Purifiers. acquired entity has presence and c. Date of Incorporation: 07/06/2020 any other significant information (in brief) d. Last 3 years turnover: FY 26 Rs. 1,45,60,000 FY 25 Rs. 35,41,484 FY24 Rs. 47,68,000 e. country in which the acquired entity has presence: India lndo National Limited I Corporate office address: Pottipati Plaza, 3rd Floor, 77, Nungambakkam High Road, Chennai – 600034. Registered office address: No. 609, Mount Road, Lakshmi Bhawan IVth FLOOR, Chennai- 600006. CIN No: L31909TN1972PLC006196 I feedback@nippo.in I 044-2827 2711, 044-2824 2700 I www.nippo.in